Allergic Conjunctivitis: Everything You Need to Know
Types, Causes, Treatment, and More
Source: yahoo.com
Allergic Conjunctivitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Allergic Conjunctivitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Allergic Conjunctivitis Today - Breaking & Trending Today
Allergy Relief In Sight: Immunotherapy For Allergic Conjunctivitis
Allergen immunotherapy has emerged as a promising treatment for managing allergic conjunctivitis.
Source: forbes.com
A Viral Cure For Pink Eye? Bacteriophages Show Promise As A Therapeutic Option
The cost of managing bacterial conjunctivitis in the United States annually amounts to 857 million US dollars.
Source: forbes.com
Lebrikizumab Gets the Nod for Treating Moderate-to-Severe Atopic Dermatitis in Europe
Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
Source: medscape.com
CHMP Recommends Marketing of Biologic for Atopic Dermatitis
Lebrikizumab is a monoclonal antibody that binds to cytokine IL-13, which has been implicated in driving the type-2 inflammatory loop in the skin, leading to skin barrier dysfunction.
Source: medscape.com